Search

Memorial Sloan Kettering Cancer Center (MSK) announced today that physician-scientist Karuna Ganesh, MD, PhD, has been awarded a Cancer Grand Challenges grant, a prestigious global initiative that provides up to $25 million around five years to tackle the toughest problems in cancer research. Dr. Ganesh is part of an international team focused on developing new ways to “rewire” cancer cells and prevent treatment resistance in colorectal cancer, one of the leading causes of cancer-related deaths worldwide, and with rates rising among adults under 50.

A Q&A with Jaap-Jan Boelens, MD, PhD, Chief of the Pediatric Transplant and Cellular Therapy Service at MSK.

Cancer vaccines that use messenger RNA (mRNA) technology are an exciting new approach to develop immunotherapies for cancers with poor prognoses, such as pancreatic cancer.

Learn about MSK Kids patient Rihanna, who was born with a cancer caused by an NTRK gene mutation and received the targeted therapy larotrectinib.

Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.

In 2024, the MSK Giving community raised $511 million to advance MSK’s mission of ending cancer for life — every single dollar donated is making a real difference in the way we treat and understand cancer.

Developmental biologist Maria Jasin studies homologous recombination, which is important in DNA repair and can lead to cancer when it malfunctions.

Androgen-deprivation therapy, a mainstay of prostate cancer treatment, may give prostate cells new growth abilities, scientists at Memorial Sloan Kettering have found.